Fraser; Graeme L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fraser; Graeme L..The latest application filed is for "macrocyclic modulators of the ghrelin receptor".

Company Profile

0.21.15

Fraser; Graeme L. - Bousval BE
Fraser; Graeme L. - Rixensart BE
Fraser; Graeme L. - Quebec CA
Fraser; Graeme L. - Sherbrooke CA
Fraser; Graeme L. - Queber CA
Fraser; Graeme L - Sherbrooke CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Grant 10,065,960 - Hoveyda , et al. September 4, 2	2018-09-04
Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyraz- ines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Grant 10,065,961 - Hoveyda , et al. September 4, 2	2018-09-04
Macrocyclic Modulators of the Ghrelin Receptor App 20180110824 - Hoveyda; Hamid R. ; et al.	2018-04-26
NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders Grant 9,926,325 - Hoveyda , et al. March 27, 2	2018-03-27
Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazi- nes as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Grant 9,475,814 - Hoveyda , et al. October 25, 2	2016-10-25
Macrocyclic ghrelin receptor modulators and methods of using the same Grant 9,371,297 - Hoveyda , et al. June 21, 2	2016-06-21
Novel Nk-3 Receptor Selective Antagonist Compounds, Pharmaceutical Composition And Methods For Use In Nk-3 Receptors Mediated Disorders App 20150315199 - Hoveyda; Hamid R. ; et al.	2015-11-05
Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders Grant 9,133,235 - Marsault , et al. September 15, 2	2015-09-15
Novel Nk-3 Receptor Selective Antagonist Compounds, Pharmaceutical Composition And Methods For Use In Nk-3 Receptors Mediated Disorders App 20140371218 - Hoveyda; Hamid R. ; et al.	2014-12-18
NOVEL CHIRAL N-ACYL-5,6,7(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF App 20140275097 - Hoveyda; Hamid R. ; et al.	2014-09-18
Spatially-defined macrocycles incorporating peptide bond surrogates Grant 8,557,765 - Deslongchamps , et al. October 15, 2	2013-10-15
Methods of using macrocyclic modulators of the ghrelin receptor Grant 8,450,268 - Fraser , et al. May 28, 2	2013-05-28
Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor Grant 8,349,887 - Fraser , et al. January 8, 2	2013-01-08
Methods Of Using Macrocyclic Agonists Of The Ghrelin Receptor For Treatment Of Gastrointestinal Motility Disorders App 20120071412 - Fraser; Graeme L. ; et al.	2012-03-22
Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders Grant 8,088,733 - Fraser , et al. January 3, 2	2012-01-03
Methods Of Using Macrocyclic Modulators Of The Ghrelin Receptor App 20110288163 - Fraser; Graeme L. ; et al.	2011-11-24
Methods of using macrocyclic modulators of the ghrelin receptor Grant RE42,624 - Fraser , et al. August 16, 2	2011-08-16
Macrocyclic modulators of the ghrelin receptor Grant RE42,013 - Hoveyda , et al. December 28, 2	2010-12-28
Macrocyclic Antagonists Of The Motilin Receptor For Treatment Of Gastrointestinal Dysmotility Disorders App 20100093720 - Marsault; Eric ; et al.	2010-04-15
Spatially-defined Macrocycles Incorporating Peptide Bond Surrogates App 20090312540 - Deslongchamps; Pierre ; et al.	2009-12-17
Macrocyclic Ghrelin Receptor Antagonists And Inverse Agonists And Methods Of Using The Same App 20090275648 - Fraser; Graeme L. ; et al.	2009-11-05
Methods Of Using Macrocyclic Modulators Of The Ghrelin Receptor App 20090170757 - Fraser; Graeme L. ; et al.	2009-07-02
Spatially-defined macrocycles incorporating peptide bond surrogates Grant 7,550,431 - Deslongchamps , et al. June 23, 2	2009-06-23
Macrocyclic antagonists of the motilin receptor Grant 7,521,420 - Fraser , et al. April 21, 2	2009-04-21
Methods of using macrocyclic modulators of the ghrelin receptor Grant 7,491,695 - Fraser , et al. February 17, 2	2009-02-17
Macrocyclic modulators of the ghrelin receptor Grant 7,476,653 - Hoveyda , et al. January 13, 2	2009-01-13
Macrocyclic Antagonists Of The Motilin Receptor For Modulation Of The Migrating Motor Complex App 20080287371 - Fraser; Graeme L. ; et al.	2008-11-20
Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists Grant 7,452,862 - Deslongchamps , et al. November 18, 2	2008-11-18
Macrocyclic Ghrelin Receptor Modulators And Methods Of Using The Same App 20080194672 - Hoveyda; Hamid ; et al.	2008-08-14
Methods Of Using Macrocyclic Agonists Of The Ghrelin Receptor For Treatment Of Gastrointestinal Motility Disorders App 20080051383 - Fraser; Graeme L. ; et al.	2008-02-28
Methods of using macrocyclic modulators of the ghrelin receptor App 20070021331 - Fraser; Graeme L. ; et al.	2007-01-25
Macrocyclic modulators of the ghrelin receptor App 20060025566 - Hoveyda; Hamid R. ; et al.	2006-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.